HealthEquity Reports Record Q4 & FY26 Results, Raises FY27 Outlook, and Repurchases $301.7M in Stock

summarizeSummary

HealthEquity reported record revenue and earnings for fiscal year 2026 and the fourth quarter, driven by strong growth in HSA assets and improved margins, leading to a raised fiscal 2027 outlook.

check_boxKey Events

• Record Fiscal Year 2026 Performance

  Revenue increased 9% to $1.31 billion, net income surged 123% to $215.2 million, and non-GAAP diluted EPS rose 28% to $4.00. Adjusted EBITDA grew 20% to $566.0 million, with margins expanding to 43%.

• Strong Fourth Quarter Results

  Q4 revenue increased 7% to $334.6 million, net income grew 89% to $49.7 million, and non-GAAP diluted EPS increased 38% to $0.95. Adjusted EBITDA was up 23% to $132.9 million, with margins at 40%.

• Raised Fiscal Year 2027 Outlook

  Management now expects fiscal 2027 revenues between $1.405 billion and $1.415 billion, non-GAAP net income per diluted share of $4.56 to $4.65, and Adjusted EBITDA of $618 million to $628 million.

• Significant Share Repurchases

  The company repurchased 3.3 million shares for $301.7 million during fiscal year 2026, including $81.7 million in the fourth quarter, demonstrating a commitment to shareholder returns.

auto_awesomeAnalysis

HealthEquity delivered strong financial results for both the fourth quarter and the full fiscal year 2026, exceeding prior year performance across key metrics like revenue, net income, and Adjusted EBITDA. The significant increase in net income and Adjusted EBITDA margins indicates improved operational efficiency. Furthermore, the company's decision to raise its fiscal year 2027 guidance signals management's confidence in continued growth. The substantial stock repurchases also demonstrate a commitment to returning value to shareholders. Investors should view this filing as a strong positive indicator for the company's financial health and future prospects.